The enhanced metastasis and invasion of ovarian cancer cells can be eliminated by blocking CCL2/CCR2 signaling transduction with CCL2 neutralizing antibodies or a CCL2 gene knockout defect [54]. This evidence concerns the gene CCR2 and ovarian carcinoma.